Bedaquiline: Introducing a new drug to the MDR TB armamentarium
Indian J Tuberc
.
2016 Jul;63(3):137-138.
doi: 10.1016/j.ijtb.2016.08.003.
Epub 2016 Sep 9.
Author
Chrispin Kambili
1
Affiliation
1
Johnson & Johnson Global Public Health, 700 US Highway 202 South, Raritan, NJ 08869, USA. Electronic address: ckambili@its.jnj.com.
PMID:
27865232
DOI:
10.1016/j.ijtb.2016.08.003
No abstract available
Publication types
Editorial
MeSH terms
Antitubercular Agents / therapeutic use*
Diarylquinolines / therapeutic use*
Humans
Tuberculosis, Multidrug-Resistant / drug therapy*
Substances
Antitubercular Agents
Diarylquinolines
bedaquiline